Massively parallel jumping assay decodes Alu retrotransposition activity

The human genome contains millions of copies of retrotransposons that are silenced but many of these copies have potential to become active if mutated, having phenotypic consequences, including disease. However, it is not thoroughly understood how nucleotide changes in retrotransposons affect their jumping activity. Here, we develop a massively parallel jumping assay (MPJA) that tests the jumping potential of thousands of transposons en masse. We generate a nucleotide variant library of four Alu retrotransposons containing 165,087 different haplotypes and test them for their jumping ability using MPJA. We found 66,821 unique jumping haplotypes, allowing us to pinpoint domains and variants vital for transposition. Mapping these variants to the Alu-RNA secondary structure revealed stem-loop features that contribute to jumping potential. Combined, our work provides a high-throughput assay that assesses the ability of retrotransposons to jump and identifies nucleotide changes that have the potential to reactivate them in the human genome.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-05-08
DOI
https://doi.org/10.1038/s41467-025-59347-4
Citations
2
Primary Topic
Chromosomal and Genetic Variations
Type
article
Field-Weighted Citation Impact
3.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Massively parallel jumping assay decodes Alu retrotransposition activity

Jasmine Sims, Ajuni Sohota, Sawitree Rattanasopha, Kelly An et al.
2 citations
Nature Communications
Chromosomal and Genetic Variations
3.50
article

Massively parallel jumping assay decodes Alu retrotransposition activity

Jasmine Sims, Ajuni Sohota, Sawitree Rattanasopha, Kelly An, Lucia Carbone, Zizheng Li, Thomas J. Meyer, Martin Kircher, Nadav Ahituv, Navneet Matharu, Linbei Deng, Yan Hung, Jingjing Zhao
article en
2 citations

Abstract

The human genome contains millions of copies of retrotransposons that are silenced but many of these copies have potential to become active if mutated, having phenotypic consequences, including disease. However, it is not thoroughly understood how nucleotide changes in retrotransposons affect their jumping activity. Here, we develop a massively parallel jumping assay (MPJA) that tests the jumping potential of thousands of transposons en masse. We generate a nucleotide variant library of four Alu retrotransposons containing 165,087 different haplotypes and test them for their jumping ability using MPJA. We found 66,821 unique jumping haplotypes, allowing us to pinpoint domains and variants vital for transposition. Mapping these variants to the Alu-RNA secondary structure revealed stem-loop features that contribute to jumping potential. Combined, our work provides a high-throughput assay that assesses the ability of retrotransposons to jump and identifies nucleotide changes that have the potential to reactivate them in the human genome.

Nature CommunicationsVol. 16(1)
Oregon National Primate Research Center (US), Leidos (United States) (US), Oregon Health & Science University (US), University of California, San Francisco (US), Frederick National Laboratory for Cancer Research (US), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), University of Lübeck (DE)
Innovative Genomics Institute, National Human Genome Research Institute, National Institute of General Medical Sciences
Openalex Percentile: Top 9%
Chromosomal and Genetic Variations
3.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.